JPRN-UMIN000026277尚未招募未知
Clinical trial to investigate the efficacy and safety of fish skin-derived collagen on wall thickness in the carotid artery and clinical symptom, etc. in healthy adults and subjects with mild carotid artery hypertrophy by a double-blind parallel group comparison design - Clinical trial to investigate the efficacy and safety of fish skin-derived collagen on wall thickness in the carotid artery and clinical symptom, etc. in healthy adults and subjects with mild carotid artery hypertrophy by a double-blind parallel group comparison design
Kojinkai Medical Corporation Shin-Nihonbashi Ishii clinic0 个研究点目标入组 120 人开始时间: 2017年2月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Subjects who participated in any clinical trial within 4 months prior to administrating study foods. -Subjects who had been taking supplements or Foods for Specified Health Uses mainly composed of collagen or placenta within 6 months prior to administrating study foods, and subjects who have ever taken Natural Marin Collagen Jelly (even once). -Employees and family of implementation medical institution -Pregnant or nursing women -Subjects with low potential to comply with the study protocol and subjects who are otherwise judged by the principal investigator or sub-investigator to be inappropriate for inclusion in the study
研究者
相似试验
进行中（未招募）
1 期
Clinical Trial to investigate the efficacy and safety of ANGOCIN® Anti-Infekt N against placebo preventing urinary tract infections in catheterized patientsProphylaxis of catheter-associated chronically inflammatory recurring urinary tract infections in adult patientsMedDRA version: 20.0Level: LLTClassification code 10046544Term: Urinary infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.0Level: LLTClassification code 10007810Term: Catheter related infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-004842-27-DERepha GmbH100
进行中（未招募）
1 期
Clinical trial for examination of efficacy and safety of ANGOCIN® Anti-Infekt N versus placebo in the continous prophylaxis of chronically recurring uncomplicated cystitisContinuous prophylaxis of chronically recurring uncomplicated cystitisMedDRA version: 20.1 Level: LLT Classification code 10011786 Term: Cystitis chronic System Organ Class: 100000004862MedDRA version: 21.1 Level: PT Classification code 10063057 Term: Cystitis noninfective System Organ Class: 10038359 - Renal and urinary disordersEUCTR2013-004653-25-DERepha GmbH224
进行中（未招募）
1 期
Clinical trial for examination of efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhea-dominant irritable bowel syndrom (IBS-D)Confirmed diagnosis of diarrhea-dominant irritable bowel syndrome (IBS-D) by a specialist physician and/or internal medicine and/or general medicineMedDRA version: 26.0Level: LLTClassification code 10060845Term: Diarrhea predominant irritable bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2019-000307-32-DERepha GmbH220
进行中（未招募）
不适用
Clinical study to investigate the efficacy and safety of an estradiol containing cream (0.01 % estradiol) in patients with senile skidermatoporosis stage I and IIEUCTR2011-002464-24-DEDr. August Wolff GmbH & Co. KG Arzneimittel
已完成
不适用
Clinical study to investigate the efficacy and safety of iliac stenting in patients with peripheral arterial diseasePeripheral arterial disease(PAD), Arteriosclerosis obliterans(ASO)JPRN-UMIN000016264Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan100